Moderna Inc
MRNA · NASDAQ54.64
54.64
USD-3.23-5.58%날짜
티커
표제
원천
S&P 500 Moderna Rebound: Can Biotech Strength Cushion the AI Chip Sell-Off?
Crypto Daily
STARTS NOW! Rebel's Edge 1pm $NVDA $PANW $MRNA $GRMN 🏈 NAJARIAN SPORTS 🏴☠️ with @petenajarian NCAA: who dominated the portal what schools really dominated the portal, Pete's Top 3 NFL: Free Agency is less than a month Top 5 QBs and possible landing spots #ITSNOTANOPTION 📙 https://t.co/pdCmmm2onX
Moderna got the FDA to change its mind and review its flu vaccine after some concessions
MarketWatch
📅IT’S A BIG WEEK OF EARNINGS! 📈 $CSCO $ANET $AMAT $NBIS $HOOD $COIN $DKNG $SHOP $APP $ALAB $DDOG $NET $HUBS $PINS $SPOT $KO $KHC $MCD $WEN $CVS $MRNA $OSCR $F $RIVN $RACE $LYFT $TMUS $BP WILL DELIVER RESULTS! 💰MAKE SMARTER INVESTMENT DECISIONS WITH ‘PRO PICKS AI’: https://t.co/o9NLlYA1jt
Moderna gains on report it held talks with at least one large drugmaker
SeekingAlpha
Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
CNBC
Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K. - CNBC
CNBC
More than 800 Moderna employees will lose their jobs this year as costs are slashed
MarketWatch
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot - CNBC
CNBC
FDA approves new Moderna COVID-19 vaccine - Axios
Axios
Bloomberg reports Trump is considering pulling funding for Moderna's bird flu vaccine
Forexlive
Moderna looks to pipeline to restore battered stock after quarterly loss
MarketWatch
US awards Moderna $590 million for bird flu vaccine development - Reuters
Reuters
Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
MarketWatch
🇺🇸EARNINGS THIS WEEK: • SUPER MICRO COMPUTER • ARM HOLDINGS • QUALCOMM • ARISTA NETWORKS • PALANTIR • DATADOG • FORTINET • BLOCK • DRAFTKINGS • NOVO NORDISK • MODERNA • CVS HEALTH • FERRARI • TOYOTA • LUCID MOTOR • RIVIAN AUTOMOTIVE • AIRBNB • WYNN • MARRIOTT… https://t.co/cE7U78GI7E https://t.co/qRewq75bos
Moderna slashes research spending, trims pipeline as it looks to regain footing
MarketWatch
Cathie Wood’s Ark ETFs buy a bunch of Moderna stock after record selloff
MarketWatch
U.S. awards Moderna $176 million to produce bird flu vaccine - CNBC
CNBC
Moderna says new-generation COVID vaccine more effective than Spikevax for adults 18 and over
MarketWatch
3 actions extraordinary people take to achieve what seems impossible, from the co-founder of Moderna
CNBC
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer - CNBC
CNBC
Moderna wins second approval with vaccine targeting RSV infection - Financial Times
Financial Times
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product - CNBC
CNBC
US nears deal to fund Moderna's bird flu vaccine trial, FT reports - Reuters
Reuters
Moderna says FDA delayed RSV vaccine approval to end of May - CNBC
CNBC
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold - CNBC
CNBC
Moderna says new Covid vaccine showed stronger immune response than current shot in study
CNBC
5 stocks to watch on Thursday: Moderna, Enerplus on Chord Energy deal and more
SeekingAlpha
Moderna posts surprise quarterly profit even as COVID sales continue to slide
MarketWatch
Moderna leads development of mRNA vax in infectious diseases: Report - Investing.com India
Investing.com
Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say - Reuters.com
Reuters
Moderna confirms COVID sales guidance as shares sink on Pfizer news
MarketWatch
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand - Forbes
Forbes
Movers & Shakers: Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move
MarketWatch
